Interestingly, the level of PIGR was up‐regulated in all three cohorts and 128% higher in the cirrhosis group compared to NAFLD, consistent with the notion that increased PIGR levels may be a novel marker of disease progression (Fig EV1C). Here, PIGR is linked to metabolic dysfunction-associated steatotic liver disease.